CDH17 and colorectal cancer: Our results are in line with the recent findings that loss of CRAD in colorectal cancer disrupts F-actin polymerization and cadherin–catenin–actin complex, which then activates Wnt/β-catenin signaling and promotes tumorigenesis [37].